GPs bid for French drugsmaker Upsa
Several private equity firms and German PE-backed drugmaker Stada have submitted bids for the acquisition of Upsa, a French division of New York-based pharmaceutical giant Bristol-Myers Squibb, according to press reports.
More on Buyout
CVC raises Europe's largest ever buyout fund, securing EUR 26bn for ninth vehicle
Fund was launched in January 2023 and surpassed its EUR 25bn target, the GP said in a statement
Inspirit holds GBP 75m final close for second fund, anticipates strong carve-outs dealflow
Fund was oversubscribed and closed following a three-month fundraising process
Cathay holds final close on USD 270m for PE growth fund
France-based GP’s latest private equity fund expands its geographical focus to North America
TA Associates waltzes to USD 16.5bn fundraise
Seven-month raise for the US-based sponsor’s fifteenth vehicle bucks fundraising woes faced elsewhere
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds